Application Nr Approved Date Route Status External Links
BLA205692 None Subcutaneous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Basaglar ® Is Indicated To Improve Glycemic Control In Adults And Pediatric Patients With Type 1 Diabetes Mellitus And In Adults With Type 2 Diabetes Mellitus. Basaglar ® Is A Long-Acting Human Insulin Analog Indicated To Improve Glycemic Control In Adults And Pediatric Patients With Type 1 Diabetes Mellitus And In Adults With Type 2 Diabetes Mellitus. ( 1 ) Limitations Of Use : Not Recommended For Treating Diabetic Ketoacidosis. ( 1 ) Limitations Of Use Basaglar Is Not Recommended For The Treatment Of Diabetic Ketoacidosis.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Insulin Glargine

Comments